Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fight diseases.
30 employees · est. 2014 · Gaithersburg, United States
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
57 employees · est. 2015 · Marseille, France
Georgiamune Inc. is the older company (2014 vs 2015); ImCheck Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Georgiamune Inc. | ImCheck Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2015 |
| Headquarters | ||
| Headquarters | Gaithersburg, United States | Marseille, France |
| Employees | ||
| Employees | 30 | 57 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Grant |
| Total Funding | ||
| Total Funding | $75.00M | $193.11M |
| Funding Rounds | ||
| Funding Rounds | 2 | 7 |
| Services | ||
| Services | Reprogramming Immune Responses, Drug Design and Development, Preclinical Research, Pipeline Development | development of immunotherapeutic antibodies, immune system modulation research, clinical research in AML patients |
| Target Customers | ||
| Target Customers | Healthcare Providers, Oncologists, Immunologists, Patients with Cancer, Patients with Autoimmune Diseases, Biopharmaceutical Companies | patients with cancer, patients with infectious diseases, patients with autoimmune diseases |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Immune Signaling Pathways, Clinical Stage, Cancer Treatment, Autoimmune Diseases, Immune Therapeutics, Scientific Discovery, Reprogramming Immune System, Disease Fighting, Immune Balance, Biopharmaceuticals | Immunotherapy, Oncology, Antibody Therapeutics, Cancer Treatment, Immune Checkpoint Inhibitors, Autoimmune Diseases, Immunomodulators, Biopharmaceuticals, Drug Development, Precision Medicine |
| Website | ||
| Website | georgiamune.com | imchecktherapeutics.com |
About Georgiamune Inc.
Georgiamune Inc., founded in 2014, operates at the intersection of biotechnology, health care, and wellness. This U.S.-based clinical-stage immunotherapeutic biotechnology firm is driving innovation by reprogramming immune signaling pathways, a strategy aimed at redefining immune system responses to...
About ImCheck Therapeutics
ImCheck Therapeutics, with the slogan "Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic," is focused on designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. Their lead clinica...
We will tell you when either one moves
BounceWatch watches Georgiamune Inc. and ImCheck Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Georgiamune Inc. and ImCheck Therapeutics — by email.
Frequently Asked Questions
Compare Georgiamune Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Georgiamune Inc. on 9 Jun 2026, and ImCheck Therapeutics on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
